Trends related to aging and co-occurring disorders in HIV-infected drug users

Substance Use and Misuse

Volumn 46, Issue 2-3, 2011, Pages 233-244

  Klein, Robert S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

aging; cancer; cardiovascular risk; comorbidities; depression; dyslipidemia; hepatitis; HIV; neurocognitive dysfunction; renal disease

Indexed keywords

AGING; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL DISEASE;

AGING; CARDIOVASCULAR DISEASES; COMORBIDITY; DRUG USERS; HIV INFECTIONS; HUMANS; MENTAL DISORDERS;

EID: 79951572158     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.522843     Document Type: Article

References (129)

1. Adler, W.H., Baskar, P.V., Chrest, F.J., Dorsey-Cooper, B., Winchurch, R.A., & Nagel, J.E.(1997).HIV infection and aging: Mechanisms to explain the accelerated rate of progression in the older patient.Mechanisms of Ageing and Development, 96(1-3), 137-155. (Pubitemid 27279822)
2. Alexander, J., & Clearfield, M.(2006).Cardiovascular disease aftermenopause: A growing epidemic.Minerva Ginecologica, 58, 35-40.
3. Alexopoulos, G.S.(2005).Depression in the elderly.Lancet, 365, 1961-1970. (Pubitemid 40797508)
4. Alexopoulos, G.S., Buckwalter, K., Olin, J., Martinez, R., Wainscott, C., & Krishnan, K.(2002).Comorbidity of late-life depression: An opportunity for research in mechanisms and treatment.Biological Psychiatry, 52, 543-558. (Pubitemid 35284021)
5. Alter, M.J.(2006).Epidemiology of viral hepatitis and HIV coinfection.Journal of Hepatology, 44(Suppl.1), S6-S9. (Pubitemid 43053865)
6. Anthony, I.C., Arango, J.C., Stephens, B., Simmonds, P., & Bell, J.E.(2008).The effects of illicit drugs on theHIV infected brain.Frontiers in Bioscience, 13, 1294-1307. (Pubitemid 351594711)
7. Appel, G.(2007).Viral infections and the kidney: HIV, hepatitis B, and hepatitis C.Cleveland Clinic Journal of Medicine, 74, 353-360.
8. Araujo, A.B., O'Donnell, A.B., Brambilla, D.J., Simpson, W.B., Longcope, C., Matsumoto, A.M., et al.(2004).Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study.Journal of Clinical Endocrinology and Metabolism, 89(12), 5920-5926. (Pubitemid 39628393)
9. Arnsten, J.H., Demas, P.A., Grant, R.W., Gourevitch, M.N., Farzadegan, H., Howard, A.A., et al.(2002).Impact of active drug use on antiretroviral therapy adherence and viral suppressionin HIV-infected drug users.Journal of General Internal Medicine, 17(5), 377-381.
10. Arnsten, J.H., Freeman, R., Howard, A.A., Floris-Moore, M., Lo, Y., & Klein, R.S.(2007).Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.AIDS, 21, 617-623.
11. Arnsten, J.H., Freeman, R., Howard, A.A., Floris-Moore, M., Santoro, N., & Schoenbaum, E.E.(2006).HIV infection and bone mineral density in middle-aged women.Clinical Infectuous Diseases, 42(7), 1014-1020.
12. Bangsberg, D.R.(2008).Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.Journal of Infectious Diseases, 197(Suppl.3), S272-S278. (Pubitemid 351717317)
13. Bartlett, J.A., DeMasi, R., Quinn, J., Moxham, C., & Rousseau, F.(2001).Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults.AIDS, 15(11), 1369-1377. (Pubitemid 32663904)
14. Becker, J.T., Lopez, O.L., Dew,M.A., & Aizenstein, H.J.(2004).Prevalence of cognitive disorders differs as a function of age in HIV virus infection.AIDS, 18(Suppl.1), S11-S18. (Pubitemid 38365901)
15. Behrens, G., Dejam, A., Schmidt, H., Balks, H.J., Brabant, G., Korner, T., et al.(1999).Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.AIDS, 13(10), F63-F70. (Pubitemid 29361082)
16. Bell, J.E., Arango, J.C., & Anthony, I.C.(2006).Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.Journal of Neuroimmune Pharmacology, 1(2), 182-191. (Pubitemid 44257492)
17. Bertolote, J.M., Fleischmann, A., De Leo, D., & Wasserman, D.(2004).Psychiatric diagnoses and suicide: Revisiting the evidence.Crisis, 25(4), 147-155. (Pubitemid 39556511)
18. Bing, E.G., Burnam, M.A., Longshore, D., Fleishman, J.A., Sherbourne, C.D., London, A.S., et al.(2001).Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.Archives of General Psychiatry, 58, 721-728. (Pubitemid 32717795)
19. Bozzette, S.A., Ake, C.F., Tam, H.K., Chang, S.W., & Louis, T.A.(2003).Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.New England Journal of Medicine, 348(8), 702-710. (Pubitemid 36237039)
20. Brown, T.T., & Qaqish, R.B.(2006).Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review.AIDS, 20(17), 2165-2174. (Pubitemid 44684707)
21. Buckner, R.L.(2004).Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate.Neuron, 44, 195-208. (Pubitemid 39348840)
22. Carr, A., Samaras,K., Thorisdottir,A., Kaufmann, G.R., Chisholm, D.J., & Cooper, D.A.(1999).Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: A cohort study.Lancet, 353, 2093-2099. (Pubitemid 29278477)
23. Casey, D.A.(1994).Depression in the elderly.Southern Medical Journal, 87(5), 559-563. (Pubitemid 24157509)
24. Centers for Disease Control and Prevention.(1981).Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California.Morbidity and Mortality Weekly Report, 30(25), 305-308.
25. Centers for Disease Control and Prevention.(1992).1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.Morbidity and Mortality Weekly Report, 41(RR-17), 1-19.
26. Centers for Disease Control and Prevention.(1999).AIDS cases diagnosed in 1977 and 1998 by sex, race/ethnicity, age at diagnosis and risk exposure.HIV Surveillance Supplemental Report, 5(3), 1-12.
27. Centers for Disease Control and Prevention.(2006).Cases of HIV infection and AIDS in the United States, by race/ethnicity, 2000-2004.HIV/AIDS Surveillance Supplemental Report, 12(1), 1-36.
28. Centers for Disease Control and Prevention.Diagnosis rates of HIV/AIDS among persons aged 13 and older, by area of residence, 2006-33 states and 5 U.S.dependent areas with confidential name-based HIV infection reporting.HIV/AIDS Surveillance Report (2006), 18, 1-55.
29. Chapman, D.P., & Perry, G.S.(2008).Depression as a major component of public health for older adults.Preventing Chronic Disease, 5(1).Retrieved July 28, 2008, from
30. Cherubin, C.E., & Sapira, J.D.(1993).The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later.Annals of Internal Medicine, 119(10), 1017-1028. (Pubitemid 23334659)
31. Cheruvu, S., Marks, K., & Talal, A.H.(2007).Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.Clinics in Liver Disease, 11(4), 917-943. (Pubitemid 350019027)
32. Chesney, M.A.(2000).Factors affecting adherence to antiretroviral therapy.Clinical Infectious Diseases, 30(Suppl.2), S171-S176. (Pubitemid 32268984)
33. Chiesi, A., Seeber, A.C., Dally, L.G., Floridia, M., Rezza, G., & Vella, S.(1996).AIDS dementia complex in the Italian National AIDS Registry: Temporal trends (1987-1993) and differential incidence according to mode of transmission of HIV-1 infection.Journal of the Neurological Sciences, 144, 107-113. (Pubitemid 27019165)
34. Cicero, T.J.(1980).Effects of exogenous and endogenous opiates on the hypothalamic-pituitary-gonadal axis in the male.Federation Proceedings, 39, 2551-2554. (Pubitemid 10058263)
35. Ciesla, J.A., & Roberts, J.E.(2001).Meta-analysis of the relationship between HIV infection and risk for depressive disorders.American Journal of Psychiatry, 158, 725-730. (Pubitemid 32429839)
36. Cooper, O.B., Brown, T.T., & Dobs, A.S.(2003).Opiate drug use: A potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease.Clinical Infectious Diseases, 37(Suppl.2), S132-S136. (Pubitemid 37102735)
37. Cummings, S.R., &Melton, I.L.J.(2002).Epidemiology and outcomes of osteoporotic fractures.Lancet, 359, 1761-1767.
38. The Data Collection on Adverse Events of Anti-HIV Drugs Study Group.(2006).Liver-related deaths in persons infected with the human immunodeficiency virus.Archives of Internal Medicine, 166, 1632-1641.
39. Davis, L., Uezato, A., Newell, J.M.,&Frazier, E.(2008).Major depression and comorbid substance use disorders.CurrentOpinion in Psychiatry, 21(1), 14-18. (Pubitemid 351339802)
40. DeCarli, C.(2003).The role of cererbrovascular disease in dementia.Neurologist, 9(3), 123-136.
41. Dobs,A.S., Dempsey,M.A., Ladenson, P.W.,&Polk, B.F.(1988).Endocrine disorders in men infected with human immunodeficiency virus.American Journal of Medicine, 84, 611-616.
42. Dobs, A.S., Few,W.L., Blackman, M.R., Harman, S.M., Hoover, D.R., & Graham, N.M.(1996).Serum hormones in men with human immunodeficiency virus associated wasting.Journal of Clinical Endocrinology and Metabolism, 81, 4108-4112. (Pubitemid 26380425)
43. Dube, M.P., Stein, J.H., Aberg, J.A., Fichtenbaum, C.J., Gerber, J.G., Tashima, K.T., et al.(2003).Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medical Association of the Infectious Disease Society of America and theAdultAIDS Clinical Trials Group.Clinical Infectious Diseases, 37(5), 613-627. (Pubitemid 37100800)
44. Friis-Moller, N., Reiss, P., Sabin, C.A., Weber, R., Monforte, A., El-Sadr, W., et al.(2007).Class of antiretroviral drugs and the risk of myocardial infarction.New England Journal of Medicine, 356(17), 1723-1735. (Pubitemid 46658704)
45. Friis-Moller, N., Sabin, C.A., Weber, R., d'Arminio Monforte, A., El-Sadr,W.M., Reiss, P., et al.(2003).Combination antiretroviral therapy and the risk of myocardial infarction.New England Journal of Medicine, 349(21), 1993-2003.
46. Frishman, W.H., Del Vecchio, A., Sanal, S., & Ismail, A.(2003).Cardiovascular manifestations of substance abuse.Part 1: Alcohol, amphetamines, heroin, cannabis, and caffeine.Heart Disease, 5(4), 253-271. (Pubitemid 36944831)
47. Frishman, W.H., Del Vecchio, A., Sanal, S., & Ismail, A.(2003).Cardiovascular manifestations of substance abuse.Part 1.Cocaine.Heart Disease, 5, 187-201.
48. Ganem, D.(1998).Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma.Current Clinical Topics in Infectious Diseases, 18, 237-251. (Pubitemid 128646827)
49. Geiss, L.S., Herman, W.H., Goldschmid, M.G., DeStefano, F., Eberhardt, M., Ford, E.S., et al.(1993).Surveillance for diabetes mellitus-United States, 1980-1989.Morbidity and Mortality Weekly Report Surveillance Summary, 42(2), 1-20.
50. Gibbie, T., Mijch, A., Ellen, S., Hoy, J., Hutchison, C., Wright, E., et al.(2006).Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.HIV Medicine, 7(2), 112-121.
51. Gkrania-Klotsas, E., & Klotsas, A.(2007).HIV and HIV treatment: Effects on fats, glucose and lipids.British Medical Bulletin, 84, 49-68.
52. Gorard, D.A.(2006).Escalating polypharmacy.Quarterly Journal of Medicine, 99, 797-800. (Pubitemid 44688412)
53. Gougeon, M.L., Penicaud, L., Fromenty, B., Leclercq, P., Viard, J.P., & Capeau, J.(2004).Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.Antiviral Therapy, 9(2), 161-177. (Pubitemid 38560209)
54. Grabar, S., Kousignian, I., Sobel, A., Le Bras, P., Gasnault, J., Enel, P., et al.(2004).Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age.Results from the French Hospital Database on HIV.AIDS, 18(15), 2029-2038.
55. Grimes, R.M., Otiniano, M.E., Rodriguez-Barradas, M.C., & Lai, D.(2002).Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy.Clinical Infectious Diseases, 34, 1530-1533. (Pubitemid 34553714)
56. Grinspoon, S., Corcoran, C., Lee, K., Burrows, B., Hubbard, J., Katznelson, L., et al.(1996).Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.Journal of Clinical Endocrinology and Metabolism, 81(11), 4051-4058. (Pubitemid 26380417)
57. Gupta, S.K., Eustace, J.A., Winston, J.A., Boydstun, I.I., Ahuja, T.S., Rodriguez, R.A., et al.(2005).Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.Clinical Infectious Diseases, 40(11), 1559-1585. (Pubitemid 40720806)
58. Hadigan, C., Meigs, J.B., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., et al.(2001).Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.Clinical Infectious Diseases, 32(1), 130-139. (Pubitemid 32150958)
59. Hartel, D.M., Schoenbaum, E.E., Lo, Y., & Klein, R.S.(2006).Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection.Clinical Infectious Diseases, 43, 625-631.
60. Hinkin, C.H., Hardy, D.J., Mason, K.I., Castellon, S.A., Durvasula, R.S., Lam, M.N., et al.(2004).Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse.AIDS, 18(Suppl.1), S19-S25. (Pubitemid 38365902)
61. Howard, A.A., Floris-Moore, M., Arnsten, J.H., Santoro, N., Fleischer, N., Lo, Y., et al.(2005).Disorders of glucose metabolism among HIV-infected women.Clinical Infectious Diseases, 40(10), 1492-1499. (Pubitemid 40628638)
62. Howard, A.A., Floris-Moore, M., Lo, Y., Arnsten, J.H., Fleischer, N.,&Klein, R.S.(2006).Abnormal glucose metabolism among older men with or at risk of HIV infection.HIV Medicine, 7(6), 389-396. (Pubitemid 44123250)
63. Hu, S., Sheng, W.S., Lokensgard, J.R., & Peterson, P.K.(2005).Morphine potentirates HIV-1 gp120-induced neuronal apoptosis.Journal of Infectious Diseases, 191, 886-889. (Pubitemid 40349803)
64. Ickovics, J.R., Hamburger, M.E., Vlahov, D., Schoenbaum, E.E., Schuman, P., Boland, R.J., et al.(2001).Mortality, CD4 cell count decline, and depressive symptoms among HIVseropositive women: Longitudinal analysis from the HIV Epidemiology Research Study.Journal of the American Medical Association, 285(11), 1466-1474. (Pubitemid 32221895)
65. Jaffe, H.W., Bregman, D.J., & Selik, R.M.(1983).Acquired immune deficiency syndrome in the United States: The first 1,000 cases.Journal of Infectious Diseases, 148(2), 339-345. (Pubitemid 13002478)
66. Jaffe, J.A., & Kimmel, P.L.(2006).Chronic nephropathies of cocaine and heroin abuse: A critical review.Clinical Journal of the American Society of Nephrology, 1, 655-667.
67. Justice, A.C., McGinnisa, K.A., & Atkinson, J.H.(2004).Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans aging cohort five-site study.AIDS, 18(Suppl.1), S49-S69.
68. Kaarbo, M., Lkokk, T.I., & Saatcioglu, F.(2007).Androgen signaling and its interactions with other signaling pathways in prostate cancer.Bioessays, 29, 1227-1238. (Pubitemid 350221791)
69. Kanis, J.A., Gluer, C.C., for the Committee of Scientific Advisors International Osteoporosis Foundation.(2000).An update on the diagnosis and assessment of osteoporosis with densitometry.Osteoporosis International, 11, 192-202. (Pubitemid 30216170)
70. Klein, R.S., Lo, Y., Santoro, N., & Dobs, A.S.(2005).Androgen levels in older men who have or who are at risk of acquiring human immunodeficiency virus infection.Clinical Infectious Diseases, 41, 1794-1803. (Pubitemid 41759867)
71. Langford, D., Grigorian, A., Hurford, R., Adame, A., Crews, L., & Masliah, E.(2004).The role of mitochrondrial alterations in the combined toxic effects of human immunodeficiency viral Tat protein andmethamphetamine on calbidin postitive-neurons.Journal of Neurovirology, 10(6), 327-337. (Pubitemid 40109620)
72. Law, M.R.,&Hackshaw,A.K.(1997).Ameta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: Recognition of a major effect.British Medical Journal, 315, 841-846. (Pubitemid 27420442)
73. Lee, G.A., Seneviratne, T., Noor, M.A., Lo, J.C., Schwarz, J.M., Aweeka, F.T., et al.(2004).The metabolic effects of lopinavir/ritonavir in HIV-negative men.AIDS, 18(4), 641-649. (Pubitemid 38393463)
74. Leibson, C.L., Rocca, W.A., Hanson, V.A., Cha, R., Kokmen, E., O'Brien, P.C., et al.(1997).The risk of dementia among persons with diabetes mellitus: A population-based cohort study.Annals of the New York Academy of Sciences, 826, 422-427. (Pubitemid 27478066)
75. Liu, H., Paige, N.M., Goldzweig, C.L., Wong, E., Zhou, A., Suttorp, M.J., et al.(2008).Screening for osteoporosis in men: A systematic review for an American College of Physicians guideline.Annals of Internal Medicine, 148(9), 685-701. (Pubitemid 351669114)
76. Macdonald, S., Anglin-Bodrug, K.,Mann, R.E., Erickson, P., Hathaway, A., Chipman, M., et al.(2003).Injury risk associated with cannabis and cocaine use.Drug and Alcoholol Dependence, 72(2), 99-115. (Pubitemid 37434002)
77. McArthur, J.C., Hoover, D.R., Bacellar, H., Miller, E.N., Cohen, B.A., Becker, J.T., et al.(1993).Dementia in AIDS patients: Incidence and risk factors.Multicenter AIDS Cohort Study.Neurology, 43(11), 2245-2252. (Pubitemid 23346956)
78. McGinnis, J.M., & Foege, W.H.(1999).Mortality and morbidity attributable to use of addictive substances in the United States.Proceedings of the Association of American Physicians, 111(2), 109-118. (Pubitemid 29148928)
79. McLean, A.J., & Le Couteur, D.G.(2004).Aging biology and geriatric clinical pharmacology.Pharmacological Reviews, 56, 163-184. (Pubitemid 38720828)
80. Michelson, D., Stratakis, C., Hill, L., Reynolds, J., Galliven, E., Chrousos, G., et al.(1996).Bone mineral density in women with depression.New England Journal of Medicine, 335(16), 117611-117681.
81. Moore, R.D., & Chaisson, R.E.(1999).Natural history of HIV infection in the era of combination antiretroviral therapy.AIDS, 13(14), 1933-1942. (Pubitemid 29509554)
82. Mulligan, K., Grunfeld, C., Tai, V.W., Algren, H., Pang, M., Chernoff, D.N., et al.(2000).Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.Journal of Acquired Immune Deficiency Syndromes, 23(1), 35-43. (Pubitemid 30123263)
83. Murata, H., Hruz, P.W., & Mueckler, M.(2000).The mechanism of insulin resistance caused by HIV protease inhibitor therapy.Journal of Biological Chemistry, 275, 20251-20254. (Pubitemid 30457596)
84. National Institute of Arthritis and Musculoskeletal and Skin Diseases.( 2008).Osteoporosis.Retrieved July 9, 2008, fromhttp://www.niams.nih.gov/Health Info/Bone/Osteoporosis/ default.asp
85. New York City Department of Health and Mental Hygiene.(2008).New York City HIV/AIDS Annual Surveillance Statistics.Updated November 2008.Retrieved July 2, 2008, from
86. Niaura, R., Shadel, W.G., Morrow, K., Tashima, K., Flanigan, T., & Abrams, D.B.(2000).Human immunodeficiency virus infection, AIDS, and smoking cessation: The time is now.Clinical Infectious Diseases, 31, 808-812. (Pubitemid 32295508)
87. Nogueras, M., Navarro, G., & Anton, E.(2006).Epidemiological and clinical features, response to HAART, and survival in HIVinfected patients diagnosed at the age of 50 or more.BMC Infectious Diseases, 6, 159.
88. Noor, M.A., Lo, J.C., Mulligan, K., Schwarz, J.M., Halvorsen, R.A., Schambelan, M., et al.(2001).Metabolic effects of indinavir in healthy HIV-seronegative men.AIDS, 15(7), F11-F18. (Pubitemid 32424384)
89. Nordestgaard, B.G., Benn, M., Schnohr, P., & Tybaerg-Hansen, A.(2007).Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.Journal of the American Medical Association, 298, 299-308. (Pubitemid 47080484)
90. North American Menopause Society.(2006).Management of osteoporosis in postmenopausal women: 2006 position statement of the North American Menopause Society.Menopause, 13, 340-367.
91. Palella, F.J., Jr., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., et al.(1998).Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.HIV Outpatient Study Investigators.New England Journal of Medicine, 338(13), 853-860. (Pubitemid 28135961)
92. Pan, F., Chernow, M.E., & Fendrick, A.M.(2008).Impact of fixed-dose combination drugs on adherence to prescriptionmedications.Journal of General Internal Medicine, 23(5), 611-614.
93. Panel on Antiretroviral Guidelines for Adults and Adolescents.(2009). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.Washington, DC: Department of Health and Human Services.1-161. Retrieved July 2, 2009, from http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf
94. Patel, P., Hanson, D.L., Sullivan, P.S., Novak, R.M., Moorman, A.C., Tong, T.C., et al.(2008).Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.Annals of Internal Medicine, 148(10), 728-736. (Pubitemid 351717418)
95. Pedrazzoni, M., Vescovi, P.P., Maninetti, L., Michelini, M., Zaniboni, G., Pioli, G., et al.(1993).Effects of chronic heroin abuse on bone andmineral metabolism.Acta Endocrinologica, 129(1), 42-45. (Pubitemid 23225790)
96. Perez, J.L., & Moore, R.D.(2003).Greater effect of highly active antiretroviral therapy on survival in people aged =50 years compared with younger people in an urban observational cohort.Clinical Infectious Diseases, 36, 212-218. (Pubitemid 36143421)
97. Phillips, A.N., Carr, A., Neuhaus, J., Visnegarwal, F, Prineas, R., Burman, W.J., et al.(2008).Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: Exploratory analyses from the SMART trial.Antiviral Therapy, 13(2), 177-187. (Pubitemid 351535369)
98. Phillips, A.N., Lee, C.A., Elford, J., Webster, A., Janossy, G., Timms, A., et al.(1991).More rapid progression to AIDS in older HIV-infected people: The role of CD4+ T-cell counts.Journal of Acquired Immune Deficiency Syndromes, 4(10), 970-975.
99. Rabkin, J.G., McElhiney, M.C., Rabkin, R., McGrath, P.J., & Ferrando, S.J.(2006).Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.American Journal of Psychiatry, 163(1), 59-66. (Pubitemid 43050104)
100. Rao, T.K., Filippone, E.J., Nicastri, A.D., Landesman, S.H., Frank, E., Chen, C.K., et al.(1984).Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.New England Journal of Medicine, 310(11), 669-673. (Pubitemid 14164641)
101. Raskind, R.A.(1998).The clinical interface of depression and dementia.Journal of Clinical Psychiatry, 59(Suppl.10), 9-12.
102. Riddler, S.A., Smit, E., Cole, S.R., Li, R., Chmiel, J.S., Dobs, A., et al.(2003).Impact of HIV infection and HAART on serum lipids in men.Journal of the American Medical Association, 289(22), 2978-2982. (Pubitemid 37430100)
103. Rietschel, P., Corcoran, C., Stanley, T., Basgoz, N., Klibanski, A.,& Grinspoon, S.(2000).Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.Clinical Infectious Diseases, 31, 1240-1244. (Pubitemid 32295456)
104. Rivlin, R.S.(2007).Keeping the young-elderly healthy: Is it too late to improve our health through nutrition? American Journal of Clinical Nutrition, 86, 1176-1181.
105. Rothenberg, R., Woelfel, M., Stoneburner, R., Milberg, J., Parker, R., & Truman, B.(1987).Survival with the acquired immunodeficiency syndrome: Experience with 5833 cases in New York City.New England Journal of Medicine, 317, 1297-1302. (Pubitemid 17153010)
106. Sacktor, N., Lyles, R.H., Skolasky, R., Kleeberger, C., Selnes, O.A., Miller, E.N., et al.(2001).HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998.Neurology, 56(2), 257-260. (Pubitemid 32095372)
107. Salazar, J.A., Poon, I., & Nair, M.(2007).Clinical consequences of polypharmacy in elderly: Expect the unexpected, think the unthinkable.Expert Opinion on Drug Safety, 6(6), 695-704. (Pubitemid 351308281)
108. Santoro, N., Lo, Y., Moskaleva, G., Arnsten, J.H., Floris-Moore, M., Howard, A.A., et al.(2007).Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women.Menopause, 14(5), 859-865. (Pubitemid 47517584)
109. Schoenbaum, E.E., Hartel, D., Lo, Y., Howard, A.A., Floris- Moore, M., Arnsten, J., et al.(2005).HIV infection, drug use, and onset of natural menopause.Clinical Infectious Diseases, 41(10), 1517-1524. (Pubitemid 41579999)
110. Shah, S.S., McGowan, J.P., Smith, C., Blum, S., & Klein, R.S.(2005).Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City.Clinical Infectious Diseases, 35, 1238-1243. (Pubitemid 35305872)
111. Sharrett, A.R., Ballantyne, C.M., Coady, S.A., Heiss, G., Sorlie, P.D., Catellier, D., et al.(2001).Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.Circulation, 104(10), 1108-1113. (Pubitemid 32830392)
112. Shuter, J.(2008).Forgiveness of non-adherence to HIV-1 antiretroviral therapy.Journal of Antimicrobial Chemotherapy, 61(4), 769-773. (Pubitemid 351426058)
113. Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M.H., & Yu, V.L.(1996).Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance.AIDS Care, 8(3), 261-270.
114. Substance Abuse and Mental Health Services Administration.(2006).National Survey on Drug Use and Health 2005 and 2006.Rockville, MD: Office of Applied Studies.Retrieved July 8, 2008, from http://www.oas.samhsa.gov/nsduhLatest.htm
115. Sulkowski, M.S.(2008).Management of hepatic complications in HIV-infected persons.Journal of Infectious Diseases, 197(Suppl.3), S279-S293. (Pubitemid 351717318)
116. Sulkowski, M.S., & Thomas, D.L.(2003).Hepatitis C in the HIVinfected person.Annals of Internal Medicine, 138, 197-207.
117. Szczech, L.A., Gupta, S.K., Habash, R., Guasch, A., Kalayjian, R., Appel, R., et al.(2004).The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.Kidney International, 66(3), 1145-1152. (Pubitemid 39121021)
118. Triant, V.A., Brown, T.T., Lee, H., & Grinspoon, S.K.(2008).Fracture prevalence among HIV-infected versus non HIVinfected patients in a large U.S.healthcare system.Journal of Clinical Endocrinology and Metabolism, 93(9), 3499-3504.
119. Triant, V.A., Hadigan, L.H., & Grinspoon, S.K.(2007).Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.Journal of Clinical Endocrinology and Metabolism, 92(7), 2506-2512. (Pubitemid 47037350)
120. Tumbarello,M., Rabagliati, R., de Gaetano Donati, K., Bertagnolio, S.,Montuori, E., Tamburrini, E., et al.(2004).Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy.BMC Infectious Diseases, 4, 46.
121. Tyor, W.R., & Middaugh, L.D.(1999).Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex? Journal of Leukocyte Biology, 65(4), 475-481. (Pubitemid 29160175)
122. United States Renal Data System.(2007).Annual data report 2007: ADR/atlas.Retrieved July 21, 2008, from http://www.usrds.org/adr.htm
123. Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O., et al.(2004).Higher frequency of dementia in older HIV-1 individuals: The Hawaii aging with HIV-1 cohort.Neurology, 63(5), 822-827. (Pubitemid 39297641)
124. Viard, J.P., Mocroft, A., Chiesi, A., Kirk, O., Roge, B., Panos, G., et al.(2001).Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence from the EuroSIDA study.Journal of Infectious Diseases, 183(8), 1290-1294. (Pubitemid 32281572)
125. Villette, J.M., Bourin, P., Doinel, C., Mansour, I., Fiet, J., Boudou, P., et al.(1990).Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus.Journal of Clinical Endocrinology and Metabolism, 70(3), 572-577.
126. Walli, R., Herfort, O., Michl, G.M., Demant, T., Jäger, H., Dieterle, C., et al.(1998).Treatment with protease inhibitors associated with peripheral insulin resistance and impaired glucose tolerance in HIV-1-infected patients.AIDS, 12, F167-F173. (Pubitemid 28479266)
127. Wyles, D.L., & Gerber, J.G.(2005).Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.Clinical Infectious Diseases, 40(1), 174-181. (Pubitemid 40053477)
128. Yun, L.W., Maravi, M., Kobayashi, J.S., Barton, P.L., & Davidson, A.J.(2005).Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients.Journal of Acquired Immune Deficiency Syndromes, 38(4), 432-438. (Pubitemid 40381553)
129. Zhang, L., Looney, D., Taub, D., Chang, S.L., Way, D., Witte, M.H., et al.(1998).Cocaine opens the blood-brain barrier to HIV-1 invasion.Journal of Neurovirology, 4(6), 619-626. (Pubitemid 29042068)